Lakefront Biotherapeutics ( GLPGF) - Key Metrics
GLPGF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.17 | $0.03 | $0 | $0 |
| 2026Q1 | $0.10 | $0.22 | -$1.20 | -$1.20 |
| 2025Q4 | $13.67 | $11.87 | -$0.64 | -$0.67 |
| 2025Q3 | $1.09 | -$3.10 | -$0.96 | -$1 |
| 2025Q2 | $0.99 | -$1.61 | -$1.65 | -$1.72 |
GLPGF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 204.14 |
| 2026Q1 | 0% | 32.71 |
| 2025Q4 | 0% | 0.56 |
| 2025Q3 | 0% | -2.30 |
| 2025Q2 | 0% | -3.62 |
GLPGF
Price: $26.24
52 week price:
Earnings Per Share: 10.40 USD
P/E Ratio: 4.68
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.2 billion